10.15
price up icon0.20%   0.02
after-market Dopo l'orario di chiusura: 10.15
loading
Precedente Chiudi:
$10.13
Aprire:
$10.125
Volume 24 ore:
977.25K
Relative Volume:
0.62
Capitalizzazione di mercato:
$388.48M
Reddito:
$127.70M
Utile/perdita netta:
$-121.25M
Rapporto P/E:
-3.2222
EPS:
-3.15
Flusso di cassa netto:
$-120.32M
1 W Prestazione:
-1.07%
1M Prestazione:
+0.59%
6M Prestazione:
+32.85%
1 anno Prestazione:
-38.15%
Intervallo 1D:
Value
$10.12
$10.18
Intervallo di 1 settimana:
Value
$10.10
$10.47
Portata 52W:
Value
$4.80
$18.13

Iteos Therapeutics Inc Stock (ITOS) Company Profile

Name
Nome
Iteos Therapeutics Inc
Name
Telefono
857-204-4583
Name
Indirizzo
321 ARSENAL STREET, WATERTOWN
Name
Dipendente
173
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
ITOS's Discussions on Twitter

Confronta ITOS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ITOS
Iteos Therapeutics Inc
10.15 387.33M 127.70M -121.25M -120.32M -3.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Iteos Therapeutics Inc Stock (ITOS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-28 Downgrade Wedbush Outperform → Neutral
2025-05-28 Downgrade Wells Fargo Overweight → Equal Weight
2025-05-14 Downgrade H.C. Wainwright Buy → Neutral
2025-05-14 Downgrade Leerink Partners Outperform → Market Perform
2025-05-13 Downgrade JP Morgan Overweight → Neutral
2024-08-13 Iniziato Wells Fargo Overweight
2021-05-05 Iniziato H.C. Wainwright Buy
2020-10-08 Iniziato Robert W. Baird Outperform
2020-08-18 Iniziato JP Morgan Overweight
2020-08-18 Iniziato Piper Sandler Overweight
2020-08-18 Iniziato SVB Leerink Outperform
2020-08-18 Iniziato Wedbush Outperform
Mostra tutto

Iteos Therapeutics Inc Borsa (ITOS) Ultime notizie

pulisher
Jul 24, 2025

SHAREHOLDER ALERT: Morris Kandinov Investigating AVDX, - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Is iTeos Therapeutics Inc. stock overhyped or has real potentialFree Predictions - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives iTeos Therapeutics Inc. stock priceRapid growth opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about iTeos Therapeutics Inc. stockConsistent high-yield stocks - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

iTeos Therapeutics Inc. Stock Analysis and ForecastUnprecedented profits - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Assessing the Fairness of iTeos Therapeutics' $10.047-per-Share Acquisition Offer: A Valuation Deep Dive - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

ITEOS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iTeos Therapeutics, Inc.ITOS - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Is iTeos Therapeutics Inc. a good long term investmentHigh-profit trading signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

iTeos Therapeutics accepts takeover bid from Concentra - The Pharma Letter

Jul 22, 2025
pulisher
Jul 22, 2025

Concentra buys beleaguered iTeos at slight discount - PharmaLive

Jul 22, 2025
pulisher
Jul 22, 2025

iTeos Therapeutics stock price target lowered to $10 at Leerink Partners - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

iTeos Therapeutics (NASDAQ:ITOS) Given Outperform Rating at Wedbush - Defense World

Jul 22, 2025
pulisher
Jul 22, 2025

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of ITeos Therapeutics, Inc. - 富途牛牛

Jul 22, 2025
pulisher
Jul 21, 2025

Securities Law Risks in Biotech M&A: A Closer Look at iTeos Therapeutics' Proposed Acquisition - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS and ZIMV on Behalf of Shareholders - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 21, 2025

Rowley Law PLLC Investigates iTeos Therapeutics Acquisition for Securities Law Violations - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Navigating ITOS Stock: ITeos Therapeutics Inc Journey - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

iTeos Therapeutics To Be Acquired by Concentra Biosciences - citybiz

Jul 21, 2025
pulisher
Jul 21, 2025

ITOS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of iTeos Therapeutics, Inc. Is Fair to Shareholders - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

Vor Bio Appoints Biotech Industry Leaders Alexander (Bo) Cumbo and Michel Detheux, Ph.D. to Board of Directors - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

Concentra To Acquire ITeos - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

The Strategic Rationale and Valuation Implications of Concentra Biosciences' Acquisition of iTeos Therapeutics - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

iTeos Therapeutics, Inc. Enters Merger Agreement with Concentra Biosciences, LLC for $10.047 per Share Acquisition - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

iTeos Therapeutics Enters into Agreement to Be Acquired by - GlobeNewswire

Jul 21, 2025
pulisher
Jul 19, 2025

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones - Informazione.it

Jul 19, 2025
pulisher
Jul 18, 2025

What risks could impact iTeos Therapeutics Inc. stock performanceFree Stock Index Interpretation - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace

Jul 18, 2025
pulisher
Jul 17, 2025

GSK and Iteos Therapeutics’ Promising Phase 3 Study on NSCLC Treatment - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

How iTeos Therapeutics Inc. stock performs during market volatilityFree Stock Market Expert Consultation - Newser

Jul 17, 2025
pulisher
Jul 15, 2025

What makes iTeos Therapeutics Inc. stock price move sharplyStrategic High Profit Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why iTeos Therapeutics Inc. stock attracts strong analyst attentionFree Stock Market Query - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

GSK and iTeos Therapeutics Advance Phase 3 NSCLC Study with Belrestotug and Dostarlimab - TipRanks

Jul 15, 2025

Iteos Therapeutics Inc Azioni (ITOS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):